Table 1.

Clinicopathological summary for mucosal head and neck patient cohort

Patients	Complete Response	Incomplete Response
n = 119	108	11
Gender
Male	89 (82.4%)	9 (81.8%))
Female	19 (17.6%)	2 (18.2%)
< 60	59 (54.6%)	3 (27.3%)
≥ 60	49 (45.4%)	8 (72.7%)
Cancer location
Oral Cavity	14 (13.0%)	7 (63.6%)
Oropharynx	88 (81.5%)	3 (27.3%)
Hypopharynx	1 (0.9%)	0 (0%)
Larynx	3 (2.8%)	1 (9.1%)
Unknown	2 (1.8%)	0 (0%)
Tumour stage (AJCC 8th Ed)
I	44 (40.7%)	3 (27.3%)
II	33 (30.6%)	1 (9.1%)
III	22 (20.4%)	3 (27.3%)
IVa or IVb	9 (8.3%)	4 (36.4%)
Tumour p16 status
Positive	90 (83.3%)	3 (27.3%)
Negative	10 (9.3%)	6 (54.5%)
no data	8 (7.4%)	2 (18.2%)
CTC status
CTC positive	50 (46.3%)	10 (90.9%)
CTC negative	58 (53.7%)	1 (9.1%)